Studi Penatalaksanaan dan Ketepatan Pengobatan Antihipertensi pada Wanita Hamil di RSUD Toto Kabila

Madania Madania, Widy Susanti Abdulkadir, Endah Nurrohwinta Djuwarno, A.Mu'thi Andy Suryadi, Sherina Sherina

Abstract


Hypertension is a condition that can affect pregnancy. High blood pressure during pregnancy can hinder fetal and uterine growth, lead to fetal death in the womb, and result in premature birth. These complications can be minimized with appropriate antihypertensive therapy. The objective of this study is to determine the incidence rate, management, and accuracy of antihypertensive treatment according to the reference standards of the 2016 Preeclampsia National Medical Service Guidelines (PNPK). This research was an observational descriptive study where the data obtained were secondary data collected retrospectively from medical records at Regional Public Hospital of Toto Kabila from September 2022 to May 2023. The sample was taken using a saturated sampling technique, so the sample in this study included all pregnant women diagnosed with preeclampsia. The results of the study obtained 65 patients, consisting of 36 severe preeclampsia patients and 29 mild preeclampsia patients. The study showed that hypertension in pregnant women was often found in the age group of 26-35 years, with 25 patients (39%), and in the third trimester of pregnancy, with 23 cases, while 2 experienced hypertension in the first trimester. 12 patients were diagnosed with severe preeclampsia and 13 patients with mild preeclampsia. The treatment of hypertension in pregnant women for mild preeclampsia included methyldopa (34%) and nifedipine (7%). For severe preeclampsia, single therapy included methyldopa (39%), amlodipine (8%), and combination therapy such as nifedipine + methyldopa (36%) and methyldopa + amlodipine (17%). The accuracy of antihypertensive drug use in pregnant women based on the 2016 Preeclampsia PNPK was 86%, including appropriate indications, correct drugs and correct doses.


Keywords


Antihypertensive; Pregnancy; Preeclampsia Regional Public; Hospital of Toto Kabila

Full Text:

PDF

References


Kaimmudin, Liawati, Damayanti, P., and Hendro, B. (2018). “Hubungan Usia Ibu Saat Hamil Dengan Kejadian Hipertensi Di RSU GMIM Pancaran Kasih Manado.” e-journal Keperawatan (e-Kp) 1(6): 1–5.

Alvionita, Reza, I. S., Murwati. (2022). “Faktor-Faktor Yang Berhubungan Dengan Kejadian Hipertensi Kehamilan Di Rsud Curup Tahun 2022.” 10(2): 198–209.

Susanto, Hadian. (2021). “Profil Kesehatan 2021.” Tinjauan-Pustaka-Kesehatan 3: 103–11.

Dewi, N. M. R. K. (2021). Pola Pengobatan Antihipertensi pada Pasien Preeklampsia di Rumah Sakit Harapan Bunda. Jurnal Sosial dan Sains, 1(7), 637-644.

Team MMN. (2017). Basic Pharmacology and Drug Notes. Makassar: Medical Mini Notes Publishing.

Ardhany, S. D. (2019). Gambaran Penggunaan Obat Antihipertensi pada Pasien Preeklampsia di Instalasi Rawat Inap Rumah Sakit Bhayangkara Kota Palangka Raya Tahun 2016: Description of the Use of Antihypertensive Drugs in Preeclamptic Patients in the Inpatient Installation of Bhayangkara Hospital, Palangka Raya City in 2016. Jurnal Surya Medika (JSM), 4(2), 17-25.

Andriana, D. D., Utami, E. D., & Sholihat, N. K. (2018). Evaluasi penggunaan obat antihipertensi pada pasien pre-eklampsia rawat inap di RSUD Prof. Dr. Margono Soekarjo Purwokerto. Acta Pharmaciae Indonesia: Acta Pharm Indo, 6(1), 29-39.

Depkes, (2019), Hipertensi Penyakit Paling Banyak Diidap Masyarakat, Departemen Kesehatan RI, Jakarta.

Khayati, Y. N., & Veftisia, V. (2018). Hubungan stress dan pekerjaan denganpreeklampsia di wilayah kabupaten semarang. Indonesian Journal of Midwifery (IJM), 1(1).

White, I. P. F. I., Rahma, R., Miranti, M., & Ibtisam, I. (2020). Analisis Faktor Risiko Kejadian Preeklampsia Di Puskesmas Talise Tahun 2018. Healthy Tadulako Journal (Jurnal Kesehatan Tadulako), 6(3), 52-61.

Ramadhan, M. F. Y., Mulyani, T., & Ariyani, H. (2022). Evaluation Of The Use Of Antihypertensive Medicines Inpatient Preeclampsia Patients In Datu Sanggul Rantau Hospital. JCPS (Journal of Current Pharmaceutical Sciences), 5(2), 514-523.

POGI. 2016. “PNPK Diagnosis Dan Tatalaksana Preeklampsia.” : 1–48.

Dewie, A., Pont, A. V., & Purwanti, A. (2020). Hubungan umur kehamilan dan obesitas ibu hamil dengan kejadian preeklampsia di wilayah kerja Puskesmas Kampung Baru Kota Luwuk. Promotif: Jurnal Kesehatan Masyarakat, 10(1), 21-27.

Sholiha, F. H. (2020). Evaluasi Ketepatan Penggunaan Obat Antihipertensi pada Ibu Hamil dengan Preeklampsia di RSUD dr. H. Moh. Anwar Sumenep Periode Januari-September 2019 (Doctoral dissertation, Universitas Islam Negeri Maulana Malik Ibrahim).

Maisarah, R. H. (2021). Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Ibu Hamil Dengan Preeklampsia Di Rsud Abdul Wahab Sjahrani Samarinda Periode Januari-Desember 2020. Prosiding Sekolah Tinggi Ilmu Kesehatan Samarinda, 1, 19-28.

Chambali, M. A., Meylina, L., & Rusli, R. (2019). Analisis Efektivitas Biaya Penggunaan Obat Antihipertensi pada Pasien Preeklampsia di RSUD Abdul Wahab Sjahranie Periode 2018. In Proceeding of Mulawarman Pharmaceuticals Conferences (Vol. 10, pp. 32-37).

Yani, Yovita Afriana, Nur Oktavia, and Magi M. T. R. (2021). “Evaluasi Penggunaan Obat Antihipertensi Pasien Preeklampsia Di Instalasi Rawat Inap RSUD Prof. Dr. W.Z Johannes Kupang.” CHM-K Pharmaceutical Scientific Journal 4(1): 242–248.

Julaeha, E., Amal, S., & Arfania, M. (2021). Profil Peresepan Obat Antihipertensi Dan Interaksi Obat Pada Pasien Pre-Eklampsia Di Rs X Karawang. Jurnal Buana Farma, 1(4), 29-35.

Norma D,N. (2013). Asuhan Patologi Teori Dan Tinjauan Kasus. Jakarta: Mustika Dwi S Nu Med.

Wulandari, A., Solikhah, U., Sulistiyowati, R., & Dhanti, K. R. (2022). Hubungan Kadar Protein Urin Dengan Tekanan Darah Pada Ibu Hamil Trimester II dan III di Puskesmas Madukara 1 Banjarnegara. ULIL ALBAB: Jurnal Ilmiah Multidisiplin, 1(10), 3503-3510.

Eryka, Siswanti, & Hilmi. (2017). Hubungan Gaya Hidup Ibu Hamil Dengan Kejadian Preeklampsia. Fakultas Kedokteran Universitas Airlangga, 1:2, 1–7.

Wilfried G. (2019). Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications. Journal of Clinical Medicine. Doi:10.3390/jcm8030335.

Tahar, N., Parenta, E. D. S., Febriyanti, A. P., Rusdi, M., & Mumthi’ah Al Kautsar, A. (2021). Evaluasi Tepat Penggunaan Obat Lini Pertama dan Lini Kedua Antihipertensi pada Pasien Preeklampsia: A Literatur Review. Jurnal Midwifery, 3(2).

Elliott W.J. and Ram C.V.S., (2011), Calcium channel blockers, Journal of Clinical Hypertension, 13 (9), 687–689.

Azzahra, A. F., & Yulianti, T. (2020). Identifikasi Drug Related Problems (DRPS) Kategori Pemilihan Obat Dan Dosis Pada Pasien Preeklampsia Dan Eklampsia Di Instalasi Rawat Inap RSUP Dr. Soeradji Tirtonegoro Klaten Tahun 2018 (Doctoral dissertation, Universitas Muhammadiyah Surakarta).

Novianty, dkk. (2019). Rasionalitas Penggunaan Antagonis Kalsium Pada Wanita Hamil. Biomedical Journal of Indonesia. Volume 5. Nomor 2.

Untari, E. K., Agilina, A. R., & Susanti, R. (2018). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi di Puskesmas Siantan Hilir Kota Pontianak Tahun 2015. Pharmaceutical Sciences and Research, 5(1), 6.

Saputri, G. A. R., Ulfa, A. M., & Jannah, M. (2020). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Pada Pasien Preeklampsia Rawat Inap Di Rsud Jend. Ahmad Yani Metro Periode Tahun 2019. Jurnal Farmasi Malahayati, 3(2), 139-150.

Tutoli, T. S., & Rasdiana, N. (2021). Pola Penggunaan Obat Antihipertensi Pada Pasien Hipertensi. Indonesian Journal of Pharmaceutical Education, 1(3), 127-135.

ACOG. 2019. ACOG Practice Bulletin Gestational Hypertension and Preeclampsia. Obstetrics and Gynecology. Volume 133, Nomor 1:1–25.

Febrianti, A. I. (2022). Evaluasi rasionalitas penggunaan obat antihipertensi pada pasien preeklampsia berat tahun 2021 di RSUD Syarifah Ambami Rato Ebu Bangkalan (Doctoral dissertation, Universitas Islam Negeri Maulana Malik Ibrahim).




DOI: https://doi.org/10.37311/jsscr.v6i1.23785

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Journal Syifa Sciences and Clinical Research

EDITORIAL OFFICE OF JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH
  Department of Pharmacy, Gorontalo State University
Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia
 Email: info.jsscr@ung.ac.id
Google Scholar : JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Creative Commons License

Journal Syifa Sciences and Clinical Research (JSSCR) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.